Search

The Academic Nursing Unit's short course program uses a face-to-face ‘speak with an expert’ model to build your patient-management knowledge and skills.  How to enrol in and attend an Academic Nursing Unit short... Read more

Patients with a rare blood cancer that had relapsed or become resistant to treatment have shown a high response rate to a potent new immunotherapy drug, in a Peter Mac-led clinical trial. The early-phase NP30179 trial involved... Read more

Peter Mac scientists have found a way to use the powerful gene editing tool CRISPR to silence cancer-causing gene mutations which, up to now, have remained off-limits to targeted drugs. Dr Mohamed Fareh and colleagues have shown... Read more

Researchers at Peter Mac will benefit from an injection of funding from the Medical Research Future Fund (MRFF). The funding boost will help researchers across Peter Mac continue their collaborative work to improve outcomes... Read more

“Brain-POP” will place Melbourne at the fore of brain cancer research and drive development of more targeted and personalised treatments. The world-first clinical trial platform will hand scientists a powerful new tool... Read more

Peter Mac is proud to be part of a private-public partnership announced yesterday, which will strengthen Australia's position at the forefront of the cancer treatment revolution. The Precision... Read more